|

Metformin 1000 mg Oral Tablet Clinical Trials

1 actively recruiting trial

Pipeline

Phase 3: 1

Top Sponsors

  • University College, London1

Indications

  • Alzheimer Disease Dementia1
  • Mild Cognitive Impairment Due to Alzheimer's Disease1
  • Alzheimer's Disease (AD)1
  • Alzheimer's Disease1

Other1 trial

An Evaluation of Treatments for Sustained Clinical Response (18 Months) in Symptomatic Alzheimer's Disease
Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.